Linkage disequilibrium (LD) has been used to map chromosomal regions regulating quantitative traits, also called quantitative trait loci (QTLs). With the increasing number of available mouse polymorphic genetic markers, LD can be estimated for the purpose of fine-mapping a given QTL or in the identification of novel QTLs. A whole-genome LD analysis was conducted for mapping mouse lung tumor susceptibility QTLs in 25 strains of mice with known susceptibility to lung cancer using 5638 genetic markers. A total of 63 markers were found to be significantly associated with lung tumor susceptibility, many of which were novel QTLs. This study demonstrates the feasibility of using LD to map QTLs on a whole genome level. Further characterization of the newly identified lung tumor susceptibility QTLs may lead to the identification of genes whose human homologue may predispose some individuals to lung cancer.
Linkage disequilibrium (LD) has been used to map chromosomal regions regulating quantitative traits, also called quantitative trait loci (QTLs) . With the increasing number of available mouse polymorphic genetic markers, LD can be estimated for the purpose of fine-mapping a given QTL or in the identification of novel QTLs. A whole-genome LD analysis was conducted for mapping mouse lung tumor susceptibility QTLs in 25 strains of mice with known susceptibility to lung cancer using 5638 genetic markers. A total of 63 markers were found to be significantly associated with lung tumor susceptibility, many of which were novel QTLs. This study demonstrates the feasibility of using LD to map QTLs on a whole genome level. Further characterization of the newly identified lung tumor susceptibility QTLs may lead to the identification of genes whose human homologue may predispose some individuals to lung cancer. Oncogene (2002 Oncogene ( ) 21, 6858 -6865. doi:10.1038 Keywords: mouse; linkage disequilibrium; lung tumor; susceptibility; gene mapping Lung cancer is the leading cause of cancer death in men and women in the United States (Greenlee et al., 2000) . Despite major therapeutic advances in recent years, most lung cancers are disseminated at the time of presentation and have a mortality rate of about 90% (Greenlee et al., 2000) . Cancer development is progressive, involving an accumulation of genetic mutations with time that conduce a multistage process involving many regulatory genes in cells Minna, 1993) . Studies of familial aggregation of lung cancer suggest that genetic factors are involved in human lung tumor development (Goffman et al., 1982; Lynch et al., 1986; McDuffie, 1991; Sellers et al., 1987; Shaw et al., 1991; Tokuhata and Lilienfeld, 1963) . Specifically, segregation analyses of lung cancer proband families indicate that a Mendelian codominant inheritance of a rare major autosomal gene is involved (Sellers et al., 1990) . This locus has been shown to account for 69, 47 and 22% of the cumulative incidence of lung cancer in patients aged 50, 60 and 70 years, respectively (Sellers et al., 1990) . Several groups are currently pursuing identification of this gene. In addition to this locus, several other genetic factors have been linked to lung cancer susceptibility. For example, a K-ras intron polymorphism and tandem repeats in the H-ras 3'-untranslated region have been found to correlate with increased lung cancer incidence (Manenti et al., 1997; Sugimura et al., 1990) . Lung cancer also occurs more frequently in individuals with genetic syndromes such as LiFraumeni syndrome (LFS), hereditary retinoblastoma, familial breast cancer (BRCA1), and Bloom syndrome (German, 1993; Johannsson et al., 1996; Li et al., 1988; Sanders et al., 1989; Strong et al., 1984) . Finally, genetic polymorphisms in genes (e.g., CYP2D6, CYP1A1, and GSTM1) responsible for metabolism of tobacco carcinogens are implicated in susceptibility to lung cancer (Caporaso et al., 1992; Shields and Harris, 1993; To-Figueras et al., 1996) .
Given their phylogenetic proximity, many of the known genetic changes in lung cancer are likely common to both human and mouse lung tumors (You and Bergman, 1998) . With the availability of inbred strains having marked differences in lung tumor susceptibility, these mice are a valuable model for studying tumor susceptibility, stages of tumor development, and the interaction of genetic and environmental factors which predispose to neoplasia (Malkinson, 1989) . Several mouse lung tumor models have been utilized to determine the genetic basis of susceptibility to chemical induction of lung tumors in the hope that such information may lead to the identification of human lung cancer susceptibility gene(s) . Identifying the major mouse lung tumor susceptibility genes has been the focus of several research groups . Linkage analysis is the most frequently used method in doing so. Recently, Tripodis et al. (2001) through large-scale linkage analyses with crosses made from a few congenic mouse strains reported 30 genes and 25 interactions affecting mouse lung tumor susceptibility. While linkage analysis provides reasonable mapping resolutions for crosses of selected mouse strains using a moderate density of genetic markers, it does not take full advantage of highly dense coverage of markers which has now become available because of the limited meiosis in the crosses. Consequently, linkage analysis using F2 or backcross populations of mice resolves QTL to within an average of *20 cM resolution due to rare opportunities for recombination in one generation between closely linked loci.
Linkage disequilibrium (LD) is defined as the association of alleles at one locus with alleles at another nearby locus, which is maintained due to a low frequency of recombinations between proximate markers (Ott, 1999) . LD analysis has been widely used for fine-mapping genes in human complex genetic diseases (Reich et al., 2001) . The use of LD in mapping mouse QTLs has been reported only recently (Grupe et al., 2001; Manenti et al., 1999) . Manenti et al. (1999) screened for LD using dense genetic markers on a small region of chromosome 6 to resolve the region containing the pulmonary adenoma susceptibility 1 (Pas1) gene. Grupe et al. (2001) proposed a computational method to extend LD to predict genes for complex murine phenotypes using SNP markers. LD methods can be applied to strains with phenotypic differences rather than to specific crosses, since the techniques search for ancestral haplotypes rather than relying on recent recombinations. To our knowledge, there have been no reports of genome-wide LD analysis for mouse lung tumor susceptibility QTLs. Herein, we report our data obtained from whole-genome LD analyses based on 5638 genetic markers and known lung tumor phenotypes in 25 strains of mice.
A total of 25 mouse strains (AKR, C3H, C57, C57BR/cdJ, C57L/J, C58, DBA/2, M. spretus, SJL/J, SM/J, 129, 129/Sv, BALB/c, BALB/cByJ, CBA, Lp, MA, PL/J, RF/J, RIIIS/J, ST/bJ, A/J, O20, STS, SWR) were selected for LD analysis based upon the availability of both phenotypic data defining lung tumor susceptibility to a lung carcinogen (i.e., urethane) and genotypic data on polymorphic genetic markers (Malkinson, 1989; Manenti et al., 1999; Chen et al., 1994) . These strains fall into three phenotype categories: resistant (AKR, C3H, C57, C57BR/cdJ, The two horizontal lines in each plot indicate the two significance levels of 7log (P)=1.3 (or P=0.05), and 7log (P)=2.0 (or P=0.01). This figure was produced with the 7log(P) value of lung tumor susceptibility for each marker against its genetic position (cM) across each of the 20 chromosomes. The P value for each marker was computed using Fisher-exact test, which is a standard statistical method for testing association of two categorical factors (here marker types and cancer susceptibilities). The P value reflects the probability of random association between the two factors. Significantly small P value indicates non-random association, or linkage disequilibrium in our case C57L/J, C58, DBA/2, M. spretus, SJL/J, SM/J), intermediate (129, 129/Sv, BALB/c, BALB/cByJ, CBA, Lp, MA, PL/J, RF/J, RIIIS/J, ST/bJ), and susceptible (A/J, O20, STS, SWR) (Malkinson, 1989; Manenti et al., 1999; Chen et al., 1994) . Polymorphisms of the strains on a total of 5638 genetic markers, including 73 biochemical markers and 5565 DNA markers (mostly SSLP markers), were obtained from web sites of Mouse Genome Informatics (MGI) (http:// www.informatics.jax.org), the Center for Inherited Disease Research (CIDR) (http://www.cidr.jhmi.edu/ mouse/mouse.html), and Whitehead Institute/MIT Center for Genome Research (http://www.genome.wi.-mit.edu/ftp/distribution/mouse_sslp_releases/). These markers were screened from an initial *7000 markers by removing those markers with less than 6 strains typed or with no genetic mapping information. All markers span the mouse genome at an average density of 51 cM.
Fisher's exact tests were conducted using r6c contingency tables (one for each marker) to detect the associations (or LD) of each marker with mouse lung tumor susceptibility, where r (r52) stands for the number of alleles of the marker under test, and c for the number of categories of the tumor susceptibility (c=3 for our study) as previously described (Manenti et al., 1999) . All analyses were conducted using S-Plus 2000 for Windows. The probability (P) obtained for each marker by Fisher's exact tests was transformed to the corresponding negative logarithm value, 7log (P). Two commonly used significance levels (P=0.05 and 0.01, or 7log (P)=1.30 and 2.0) were used to select markers having reasonably strong associations with mouse lung tumor susceptibility. Figure 1 shows the results from the whole-genome LD analyses. A total of 63 markers were found to have significant (P50.05) to highly significant (P50.01) association (Table 1 ). The first three markers, D4Mit2, D6Mit26, and D8Mit205, showed highly significant LDs, among which D6Mit26 (7log (P)=2.8) was reported previously (Manenti et al., 1999) . The other two markers represent novel QTLs. It is interesting to note that D4Mit2 is only 5.6 cM from D4Mit4 which was found to be involved in an interaction with D15Mit96 (Tripodis et al., 2001) . Figure 2 shows chromosomal regions in which the three markers reside. As expected, genetic markers near D4Mit2, D6Mit26, and D8Mit205 have also exhibited significant LD. Since a gradual decrease in LD surrounding each of the peak markers (D4Mit2, D6Mit26, and D8Mit205) is evident, regions can be limited to sizes of 50.2 -0.5 cM, a higher mapping resolution compared with conventional linkage analyses. The remaining 60 markers in Table 1 showed significant LDs which are suggestive of loci with intermediate effects on lung tumor susceptibility. Note that, among these markers, 8 (D4Mit181, D4Mit1, D5Mit297, D7Mit248, D10Mit2, D13Mit209, D13Mit43, and D13Mit7) are nearly highly significant (7log(P) 41.80). D4Mit181 (2.5 cM) and D4Mit1 (6.3 M) are located within the same region as D4Mit2 (6.5 cM). This suggests that a gene in this region affects lung tumor susceptibility. The three markers (D13Mit209, D13Mit43, and D13Mit7) on chromosome 13 are located at the same genetic position (37 cM), and share the same degree of linkage disequilibrium and allele pattern. This also suggests that there may be a susceptibility gene in this region. These results indicate that our global LD analyses reveal three major QTLs and as many as 27 minor QTLs. The location of the marker D6Mit26 with the most significant LD is very close to the K-ras locus on chromosome 6. K-ras has been considered a major candidate for the previously mapped Pas1 gene (Greenlee et al., 2000; Ott, 1999) . This finding is an independent confirmation of the Pas1 QTL using LD mapping. At the same time, our results confirm the validity of the LD method in mapping mouse lung tumor susceptibility QTLs. Pas1 was initially mapped in (A/J6C3H/HeJ) F 2 mice to distal chromosome 6. This locus produced a maximum logarithm of the likelihood ratio (LOD) score of 9 and accounted for approximately 45% of the observed phenotypic variance in lung tumor susceptibility between the parental strains of mice (Gariboldi et al., 1993) . A LOD score of 3 or greater is considered significant for linkage. Consistent results were obtained in comprehensive linkage studies using (A/J6C57BL/ 6J) F 2 (60% of variance), (A/J6C57BL/6J)6C57BL/ 6J (16% of variance), (A/J6M. spretus)6C57BL/6J (34% of variance), and A6B & B6A RI mice (51% of variance) (Devereux et al., 1994; Festing et al., 1994; Lin et al., 1998; Manenti et al., 1995) . Our results are consistent with a recent report of genetic mapping of the Pas1 gene to 52-Mb region of chromosome 6 using linkage disequilibrium (Manenti et al., 1999) . The Kras gene is the primary candidate for the Pas1 locus based on the following evidence: (a) activation of the K-ras gene is an early event in the development of both spontaneously occurring and chemically induced lung tumors in mice; (b) polymorphisms detected in the Kras promoter and enhancer regions in different mouse strains correlate with their susceptibility to the chemical induction of lung tumors; (c) these polymorphisms appear to be responsible for the observed allele-specific expression of the K-ras allele in hybrid mice; (d) allele-specific expression leads to allele-specific activation of the K-ras gene; and (e) genetic linkage analyses indicate a major locus only when parental mice have distinct K-ras genotypes (Greenlee et al., 2000; Grupe et al., 2001; . Additional candidates for Pas1 based upon Celera Genome Database are listed in Table 2 with all transcribed sequences (known and predicted) of known or unknown genes located within the mapped Pas1 chromosomal region.
The second locus is mapped on marker D4Mit2 which is only 5.6 cM from susceptibility to lung cancer 18 or Sluc18 (near D4Mit4) that was identified to be involved in an interaction with Sluc26 (near D15Mit96) (Tripodis et al., 2001) . Sluc genes are interactive genes that control susceptibility to lung cancer in mouse recombinant congenic (RC) strains. Sluc18 synergistically interacts with Sluc26 resulting in a greater than (Tripodis et al., 2001) . It is highly likely that the LD-mapped locus on chromosome 4 is the Sluc18 locus in RC strains of mice. Candidates for this locus based upon Celera Genome Database are listed in Table 3 with all transcribed sequences (known and predicted) of known or unknown genes located within the mapped chromosomal region.
The third major locus is located near D8Mit205 on chromosome 8. This locus has not previously been reported to be associated with lung tumor susceptibility in mice. Possible candidates for this locus are listed in Table 4 . In addition to the three major loci, at least 27 minor loci were also mapped to various locations across the mouse genome (Table 1) . Many of these mapped loci are in the vicinity of those that have been mapped previously using F2, backcross, or recombinant inbred populations of mice (Table 1) . Others are novel and most likely represent low-penetrance genes affecting lung tumor susceptibility through extensive interactions.
In the present study, we used LD mapping to assign a major new QTL located on chromosome 8 and a The position (bp) is the physical distance based on DNA sequence assembly from the extreme proximal end of the chromosome LD mapping has been widely used for mapping genes of outbred or natural populations with a long history; e.g., humans. The individuals from this type of population are all heterozygous, thus the haplotypes of markers and/or disease genes are not known unam- The position (bp) is the physical distance based on DNA sequence assembly from the extreme proximal end of the chromosome The position (bp) is the physical distance based on DNA sequence assembly from the extreme proximal end of the chromosome
Mapping of mouse lung tumor susceptibility loci D Wang et al biguously. This results in a low detection power using linkage disequilibrium analysis as compared with parametric statistical methods. With inbred strains however, each individual is actually a large haplotype at all genes across the genome assuming the ideal situation of a pure line, and thus linkage disequilibrium mapping is likely to offer a higher detection power than that for outbred populations. In fact, the present study represents one of the first attempts to conduct a genome-wide linkage disequilibrium analysis for mapping mouse lung tumor susceptibility QTLs. The mapping and identification of 63 markers showing strong associations with lung tumor susceptibility by a genome-wide LD analysis was made possible largely by a high density (51 cM) of marker coverage across the mouse genome and the availability of lung tumor susceptibility data of 25 strains of mice. This study has identified three major QTLs and perhaps as many as 27 minor QTLs associated with susceptibility to the development of lung adenomas in mice following treatment with urethane using LD analyses with 5638 genetic markers (Figures 1 and 2 and Table 1 ). However, we are cautious about the detected LDs due to the availability of only 25 mouse strains with data of both lung tumor susceptibility and marker polymorphisms, as sample size is a very important factor that affects the power and accuracy of LD analysis. In addition, other events such as clustered sampling, gene interactions, mutations, etc., may also contribute to LD, as discussed by a recent report (Ott, 1999) . 
